View as cardsView as table102 Projects
Fiscal Year Awarded
Funding amount
Principal Investigator
Targeting tau hyperphosphorylation to develop novel therapeutics for Alzheimer’s Disease and other tauopathies

2026

John Flanagan

Therapeutic development of secreted peptides uncovered by Barcoded Ligand Sequencing

2026

Michael Greenberg

Towards the development of improved insect repellents

2026

Josefina del Marmol

V8 protease to treat S. aureus infection and atopic dermatitis

2026

Isaac Chiu

Developing a biomarker of homologous recombination deficiency for enhanced PARP inhibitor efficacy across cancers

2025

Peter Park

Developing a synthetic biology platform for pharmaceutical biomanufacturing

2025

Pamela Silver

Development of allosteric activators for immunotherapy

2025

Stephen Blacklow

Development of small molecule inhibitors of a gut bacterial metabolic toxin

2025

Sloan Devlin

In vivo gene editing to treat inherited Collagen VI-related myopathies

2025

Amy Wagers

In vivo strategy to induce tolerance to therapeutic proteins and autoantigens

2025

Amy Wagers

Investigating the mode of action of a highly selective insecticide and suitability for Anopheles management

2025

Norbert Perrimon

Structure-based discovery of chromatin remodeling inhibitors

2025

Lucas Farnung

Targeting cancers by de-repressing nuclear PDC

2025

David Scadden

Targeting cell surface receptors for ASO delivery to bone marrow leukemia cells

2025

Karen Adelman

Virome screening for next generation nucleic acid delivery vectors to the lung

2025

George Church

Design of novel protease inhibitors to enhance immune checkpoint blockade in cancer therapy

2024

Mark Namchuk

Development of a synthetic promoter pipeline for safe and efficient gene therapy

2024

George Church

Development of novel AAV-mediated in vivo gene editing approaches to treat inherited collagen VI-related myopathies

2024

Amy Wagers

Functional antibody screening with micro-capsules - proof of concept with anti-EGFR

2024

Allon Klein

Gene editing to treat hereditary deafness

2024

David Corey